Email Email Print Print
Clip Clip & File

Only on :: Latest News

August 13, 2013

Johnson Matthey expands ligand manufacturing to commercial scale

Mary Page Bailey

Johnson Matthey (London; has announced that their global Catalysis and Chiral Technologies technology business unit, JMCCT, which provides services in heterogeneous, homogeneous, chiral and biocatalytic technologies for customers in the pharmaceutical, fine chemical and agrochemical industries, is expanding its existing specialty ligand manufacturing capability to include commercial-scale manufacturing up to 100 kilograms. The company has a diverse specialty ligands portfolio, and this expansion is largely focused on the Buchwald ligands from the Massachusetts Institute of Technology for customers throughout Europe, Asia and the United States.
The Buchwald ligands offered by JMCCT are a class of bulky and electron-rich dialkylbiaryl monophosphine ligands, which are used for the in situ generation of active catalysts. These ligands are used for coupling reactions in the manufacture of both pharmaceuticals and specialty chemicals and are more commonly offered at a research scale for use in the laboratory. Three separate expansion investments have now been made, focused on a new facility in Taloja, India last year and further expansion underway in Royston, U.K.

Add a Comment


Please enter the letters or numbers you see in the image. (refresh)

Related Stories

LinkedIn Groups

Our LinkedIn group is now over 33,000 members strong!

  1. Join other CPI professionals from all over the globe and share best practices, expertise, concerns and more.
  2. Provide feedback to Chemical Engineering Editors

Current members represent Worley Parsons, DuPont, SABIC, Fluor, Air Products, LyondellBasell, Nalco, Dow Chemical, Dow Corning, BASF, Jacobs Engineering, ExxonMobil, Shell, Chevron and more.

Join Now

We also offer the following subgroup for more targeted discussions:

Search the Buyers' Guide

Plant Cost Index

Facts at Your Fingertips (archive)

Ask the Experts

Back Issues
To access this area, please log in or create an account.
Forgot your password?
Request it now.
Live chat by BoldChat